Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.29 CHF | +1.75% | +0.32% | -5.30% |
25/04 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
25/04 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.30% | 116M | |
+6.87% | 72.03B | |
-10.86% | 5.14B | |
+46.43% | 4.6B | |
+5.38% | 3.96B | |
-16.20% | 2.5B | |
+22.70% | 2.43B | |
-26.20% | 2.32B | |
+19.92% | 2.18B | |
+8.15% | 1.72B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals Wins Priority Review for Duchenne Muscular Dystrophy Drug in China